Platform · How it works

From research strength to translational impact.

InovaSignal is the decision-intelligence and prioritization layer for the research enterprise. It brings external market demand inside the institution as a continuous input, then converts it into the decision each leader owns.

InovaSignal connects the institution's research strengths, live external signals, and decision-ready intelligence, so leaders can see where value concentrates and act before time, capital, and attention are committed.

How InovaSignal works · stage 1 of 5 01 / 05
INOVASIGNAL
How InovaSignal works

Most institutions read the market after critical decisions are made.

InovaSignal reverses it.

The decisions it informs
Grow or reposition capacity
Mobilize faculty clusters
Prioritize disclosures
License, startup, or hold
Where to spend patent budget
Julie Huls, Founder & CEO of InovaSignal
About

The power to change the world already lives inside our research enterprises. It becomes impact only when that research strength is matched to what the world outside actually needs. InovaSignal exists to close that gap.

InovaSignal was founded by Julie Huls, an innovation-economy strategist who has spent 20+ years helping more than 25 U.S. regions and research institutions align research strength with market opportunity, work that has supported over $300M in innovation investment.

Featured speaker: University of Utah · Association of University Research Parks (AURP) · University Economic Development Association (UEDA) · Dallas Economic Development Corporation.

Julie Huls · Founder & CEO, InovaSignal
Continuous signal

External signals, read continuously, matched to research strength.

Live & forward-looking

Funding signals

FOAs, SBIR/STTR windows, agency priorities.

312 open windows tracked
Industry pull

Market demand

Inbounds, licensing interest, startup formation.

40 inbounds · 18 active startups
Peer position

Competitive advantage

Benchmarking, rankings, emerging white space.

38 R1 peers benchmarked
Prior art & FTO

IP landscape

Patent families, filing windows, freedom-to-operate.

1,207 patents mapped

Matched against the institution's own research strength, not read once a decision is already on the table.

How it thinks

A lead researcher, not a single model.

Think of the Research Agent as a lead researcher managing a team of specialists. The lead doesn't know everything up front, but knows which expert to ask, and in what order: search, collect, compare, decide, write.

Federal funding

Funding Specialist

Searches NIH, NSF and agency funding data.

312 NIH/NSF awards · $840M tracked
Research output

Publications Specialist

Analyses output, citations and impact.

18,400 papers benchmarked
IP & commercialisation

Patent Specialist

Investigates IP position and licensing paths.

1,207 patents · 40 startups
Peer position

Benchmarking Specialist

Compares the institution against its peers.

Cross-institution

Collaboration Specialist

Finds researchers and cross-institutional links.

“Do I have enough evidence?”

Before it writes, the lead checks with a validation specialist. Not enough, and it goes back for more. Enough, and it writes, with every recommendation traced to the funding, policy, and market data behind it.

Not an opinion. Evidence you can trace.

Scored, not just tracked

Scored against readiness and demand, before spend is committed.

INOVASIGNAL
Solid-state electrolyte, thin-film
Materials · Energy storage
0.82
Grow
Adaptive optics control module
Photonics · Instrumentation
0.64
Watch
RNA delivery scaffold
Bioengineering · Therapeutics
0.38
Risk

Every signal sourced, scored, and ranked: grow, watch, or hold.

Resolved to the reader

The same intelligence, resolved to the decision each leader owns.

For the VP for Research

Where research capacity should move.

Physical AI & autonomous systems
Computing · Robotics
Grow
Semiconductors & advanced packaging
Materials · Microelectronics
Protect
Federal portfolio concentration
Cross-domain · Sponsors
Reposition
For the Chief Commercialization Officer

Where commercial value concentrates.

Solid-state electrolyte, thin-film
Materials · Energy storage
License
Adaptive optics control module
Photonics · Instrumentation
Startup
RNA delivery scaffold
Bioengineering · Therapeutics
Hold

An invention that sits idle is no longer a missed opportunity. It's unrealized impact.

The signal updates as the funding, market, and policy landscape moves, not once a year.
In their words

InovaSignal became a critical partner in helping us think strategically about our commercialization practices, industry engagement, and linking the U's research activity to technology economic impact. Their team of experts understands our vision and possesses the experience to translate it into action.

Erin Rothwell, PhD SVP of Research, University of Utah
Not another dashboard

A decision you can defend.

Intelligence for the research enterprise.

Resolved to the decision each leader owns.